Alembic launches generic Lamictal

BRIDGEWATER, N.J. — Alembic Pharmaceuticals announced Thursday that it had launched its generic of Lamictal (lamotrigine) chewable dispersible tablets. The drug is indicated as an anticonvulsant used in the treatment of epilepsy and bipolar disorder.

 

Alembic will offer the drug in 5- and 25-mg dosage strengths. This is Alembic’s 13th U.S. launch since the company began its U.S. operations.